Lack of bidirectional association between age-related macular degeneration and Alzheimer's disease: A Mendelian randomization study

Alzheimers Dement. 2022 Dec;18(12):2725-2729. doi: 10.1002/alz.12775. Epub 2022 Aug 25.

Abstract

Introduction: Observational studies have reported inconsistent results on the relationship between age-related macular degeneration (AMD) and Alzheimer's disease (AD). Therefore, we aimed to determine whether there is a causal association between AMD and AD.

Methods: This two-sample bidirectional Mendelian randomization (MR) study evaluated causal associations between advanced AMD and AD using summary data from large genome-wide association studies.

Results: Genetic liability for advanced AMD showed no statistical causal association with AD risk (odds ratio [OR] = 0.999, 95% confidence interval [CI]: 0.955-1.044, P = .948). Reverse MR analysis provided little support for a causal effect of AD on advanced AMD (OR = 0.973, 95%CI: 0.938-1.008, P = .133).

Discussion: This MR study found no evidence to support a bidirectional causality between advanced AMD and AD.

Highlights: We evaluated the bidirectional causal relationship between advanced AMD and AD. Advanced AMD showed no statistical causal association with risk of AD. We found no evidence to support a causal effect of AD on advanced AMD risk. The associations observed in epidemiological studies should not be considered causal.

Keywords: Alzheimer's disease; Mendelian randomization; age-related macular degeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / complications
  • Alzheimer Disease* / epidemiology
  • Alzheimer Disease* / genetics
  • Genome-Wide Association Study
  • Humans
  • Macular Degeneration* / epidemiology
  • Macular Degeneration* / genetics
  • Mendelian Randomization Analysis / methods
  • Polymorphism, Single Nucleotide / genetics